Median’s Revolutionary Lung Cancer Diagnostic Earns Pivotal Validation
Median Technologies’ eyonis™ LCS, an AI-powered SaMD for lung cancer screening, has demonstrated strong performance in its REALITY pivotal...
Adaptive Clinical Trial Design Adaptive Trial Design AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Artificial Intelligence in Clinical Trials Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Innovation Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies DOGE FDA Budget Cuts eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials protocol amendments Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
Median Technologies’ eyonis™ LCS, an AI-powered SaMD for lung cancer screening, has demonstrated strong performance in its REALITY pivotal...
Merck has discontinued two Phase 3 trials, KEYNOTE-867 and KEYNOTE-630. The KEYNOTE-867 trial evaluated the combination of KEYTRUDA (pembrolizumab)...
During the 2024 European Society of Cardiology (ESC) Congress, Bayer will unveil late-breaking results from the Phase III FINEARTS-HF...
Elastin Biosciences is at the forefront of developing small molecule therapies for elastin restoration. Their innovative approach aims to...
Statistics & Data Corporation (SDC), a pioneer in clinical trial biometrics, has unveiled its groundbreaking Bring Your Own Device...
Merck has launched Shorespan-007, a Phase 3 clinical trial evaluating bomedemstat for treating patients with essential thrombocythemia (ET) who...
In this interview, Tim Smith, CTO and co-founder of Medable, discusses the launch of Medable Studio, a no-code platform...
The Panagora Pharma 7th Annual Digital Biomarkers in Clinical Trials Summit recently featured a compelling presentation by Rana Zia...
Care Access, a global health research company, has partnered with the Biomedical Advanced Research and Development Authority (BARDA) to...
Bristol Myers Squibb (NYSE: BMY) showcased its robust cardiovascular franchise at the European Society of Cardiology (ESC) Congress in...